The pharmaceutical industry ve-ve market supply is still tight market - Flexible LED Strip Light

According to today's investment "online analysts" with more than 70 domestic securities firms and more than 1,800 research analysts on investment ratings of statistical data, this week among the top investment rating rise to 30 stocks, the more concentrated the industry distribution: electronic equipment and instruments industry ranked first, with eight companies selected, the pharmaceutical industry has selected three companies, machinery, metals and mining, transport infrastructure sectors have two companies selected. We chose this issue for the pharmaceutical industry comment. Global market supply remains tight VE. Round of price increases VE dynamic factors: rising costs,Soccer Training Jackets, global supply shortage VE 11.5% still exist. Global supply remains tight VE: the pressure of environmental protection, shortage of raw material supply m-cresol, synthesis complex process,Newcastle United jerseys, export certification and other factors, estimated global VE tight supply situation will remain for 1-2 years. The more rigid requirements VE: VE is to be added in the feed additive in the product, there are no other alternatives, the more rigid demand. VE growth in the global market remains: It Feedinfo estimated VE 2008 demand growth in China is about 7-8% in other developing regions in 2008, annual growth rate of 5-7%, slower growth in developed countries. Globally in 2008 50% VE demand growth at 2-4%. Major downstream impact of customer demand is not great: VE in the small proportion of the feed, the cost is modest. Feedinfo the survey, compared with 2007, premix manufacturers in mature markets in 2008 did not reduce the demand for synthetic VE. Focus on the VE price and company analysis. The price on the VE: VE in the current supply is still tight, end-customer demand and no great change, we believe that the future price of VE will remain high. Key Company Analysis: New and adult, Zhejiang Medicine Jieyou strong product R & D capability and rich reserves, and benefit from VE product prices, future net income will continue to maintain a rapid growth. Investment advice is still optimistic about the future price movements VE products, state securities analysts bullish on gold and into new, Zhejiang Medical strong product R & D capability and rich reserves, to maintain "buy" rating. Ya Bao Pharmaceutical results in line with expectations 2008 first half, Asia Bao Pharmaceutical main business income 593 million yuan, up 29.7%; to achieve operating profit 193 million yuan, up 22.15%. Operating profit of 53.85 million yuan, up 83.5%. To achieve the owner's net profit attributable to parent company 43.31 million yuan, up 128%, basically in line with expectations. Ya Bao Pharmaceutical business is "clean", mainly the pharmaceutical industry and pharmaceutical wholesaling. 21.87% growth in pharmaceutical industry, pharmaceutical wholesale growth of 38.63 percent. Sub-products, mainly including small children umbilical Gui 17.92% growth posted in the ointment,Puma Soccer Shoes, gross margin increased 2.04 percentage points. Ding Gui child umbilical posted growth is not high, can only be said to be stable. The main reason is the end of 2007 the company made the product price increases, in the first half of the shipping company to promote price control in place as soon as possible, we believe that in the second half Dinggui umbilical children may be affixed to heavy volume. Order to integrate the company's marketing resources, sharing Medical Reform Benefits, the end of 2007 the company set up specifically for community hospitals and NCMS Marketing team, responsible for the subsidiary high-margin products. The move in the first half of 2008 and achieved initial results: Sichuan subsidiary gluconate and oral calcium gluconate rapid growth of the company were up 171% oral solution, and the gross margin increased by 14.57 percent, which makes the company out of the loss; Tatung Company of pills, capsules Taiyuan company also increased rapidly, and companies are initially out of Taiyuan loss, the company reveals the healthy development of the situation. In sales revenue growth the company was 76.73 million yuan of sales charges but never reduced to 70.43 million yuan, mainly for two reasons: First, company-wide integrated marketing team, saving the cost; second, early in the marketing network and invested more advertising, resulting in a higher base, the first half of this year without adding new inputs. This factor, combined corporate income tax rate from 33% to 25%,Bayern Munich jerseys, the main reason for the company's net profit doubled. We believe that these two factors increased profits would not exist in 2009, then as their growth depends on achieving sales growth or acquisitions. I am an expert from led-plantgrowlights.com, while we provides the quality product, such as ,USA soccer jerseys, , ,and more.